Venmax Drugs Financials

BSE: 531015

₹15.20

₹0.59 (4.04%)

As on 11-Sep-2026IST

Market cap

₹22 Cr

Revenue (TTM)

₹9 Cr

P/E Ratio

78.3

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	9.29	0.81	--	--	--	0.17
Total Income	9.45	1.86	0.20	0.42	1.98	0.35
Total Expenditure	9.14	1.87	0.10	0.19	0.13	0.50
EBITDA	0.16	-1.06	-0.10	-0.19	-0.13	-0.33
Depreciation	0.00	0.01	0.01	0.01	0.01	0.01
EBIT	0.15	-1.07	-0.11	-0.19	-0.14	-0.34
Interest	0.00	0.00	--	--	--	0.00
Other Income	0.16	1.05	0.20	0.42	1.98	0.18
Exceptional Items	--	--	--	--	--	--
Profit before Tax	0.31	-0.01	0.09	0.23	1.85	-0.16
Provision for Tax	0.03	0.00	0.02	0.00	0.00	0.00
Profit after Tax	0.28	-0.01	0.06	0.23	1.85	-0.16

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	15.01	4.41	-0.65	-0.71	-0.94	-2.79
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.82	0.76	0.73	0.92	1.15	3.09
Total Liabilities	16.83	5.17	0.08	0.21	0.21	0.31

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	0.04	0.04	0.07	0.07	0.08	0.09
Current Assets	16.79	5.13	0.02	0.14	0.13	0.22
Total Assets	16.83	5.17	0.08	0.21	0.21	0.31
Total Debt*	--	0.05	0.35	0.35	0.35	2.33
Net Current Assets	14.97	4.37	-0.71	-0.78	-1.02	-2.87
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-2.29	0.00	0.00	1.91	0.26
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	4.77	--	0.00	-1.98	-0.19
Net Cash Inflow / Outflow	--	2.48	0.00	--	-0.07	0.07

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	0.31	-0.02	0.12	0.43	3.52	-0.31
Cash EPS (₹)	0.19	-0.01	0.14	0.45	3.54	-0.29
Adjusted Book Value (₹)	14.37	-1.26	-1.24	-1.36	-1.79	-5.32
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-4.37	0.00	-0.01	3.64	0.50
Free Cash Flow per Share (₹)	--	-4.40	0.00	-0.01	3.64	0.50

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	-0.64	--	--	--	--
ROE (%)	2.30	--	--	--	--	--
ROA (%)	2.35	-0.40	44.06	106.16	708.52	-42.56
EBIT Margin (%)	1.62	-132.11	--	--	--	-204.38
Net Margin (%)	2.97	-0.56	32.48	53.80	93.10	-46.51
Cash Profit Margin (%)	0.00	-0.51	--	--	--	-90.61

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	385.78	--	--	--	-100.00	-64.45
EBIT Growth (%)	114.91	-854.79	42.30	-41.94	60.25	-28.41
Net Profit Growth (%)	2,241.67	-116.28	-71.41	-87.78	1,236.38	40.62
EPS Growth (%)	1,071.93	-116.25	-71.41	-87.78	1,236.38	40.62
Book Value Growth (%)	--	-1.62	9.03	24.00	66.26	-6.19

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	78.35	--	--	--	--	--
Price / Book Value	1.06	-22.62	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	67.95	-1,812.83	59.39	23.91	3.01	-49.51
Close Price (₹)	17.53	28.52	--	--	--	--
High Price (₹)	36.96	30.88	--	--	--	--
Low Price (₹)	16.31	6.27	--	--	--	--
Market Cap (₹ Cr)	22.02	14.94	--	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	-0.08	-0.54	-0.49	-0.37	-0.84
Short term debt to equity ratio	--	0.01	-0.54	-0.49	-0.37	-0.84
Current Ratio	9.24	6.78	0.02	0.15	0.12	0.07
Quick Ratio	8.04	6.70	0.02	0.15	0.12	0.07
Interest Coverage	311.00	-16.63	--	--	--	-1,286.18

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	17.32	118.00	--	--	--	21.57
Asset Turnover	0.78	0.31	--	--	--	0.44
Receivable days	--	430.69	--	--	--	80.65
Inventory Days	--	26.00	--	--	--	--
Payable days	--	168.15	--	--	--	537.43
Cash Conversion Cycle	--	288.55	--	--	--	-456.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.